A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 13, Issue 7, Pages 1640-1652
Publisher
Informa UK Limited
Online
2017-05-23
DOI
10.1080/21645515.2017.1313375
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Model estimates of the burden of outpatient visits attributable to influenza in the United States
- (2016) Gonçalo Matias et al. BMC INFECTIOUS DISEASES
- Impact of quadrivalent influenza vaccine on public health and influenza-related costs in Australia
- (2016) Aurélien Jamotte et al. BMC PUBLIC HEALTH
- Modelling estimates of age-specific influenza-related hospitalisation and mortality in the United Kingdom
- (2016) Gonçalo Matias et al. BMC PUBLIC HEALTH
- Patterns of influenza B circulation in Brazil and its relevance to seasonal vaccine composition
- (2016) Eliana Nogueira Castro de Barros et al. Brazilian Journal of Infectious Diseases
- A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults
- (2016) Stéphane Pillet et al. CLINICAL IMMUNOLOGY
- Influenza vaccine effectiveness in adults 65 years and older, Denmark, 2015/16 – a rapid epidemiological and virological assessment
- (2016) Hanne Dorthe Emborg et al. Eurosurveillance
- Assessment of potential public health impact of a quadrivalent inactivated influenza vaccine in Thailand
- (2016) Wanitchaya Kittikraisak et al. Influenza and Other Respiratory Viruses
- Trivalent and quadrivalent influenza vaccination effectiveness in Australia and South Africa: results from a modelling study
- (2016) George J. Milne et al. Influenza and Other Respiratory Viruses
- Cost-Effectiveness and Public Health Effect of Influenza Vaccine Strategies for U.S. Elderly Adults
- (2016) Jonathan M. Raviotta et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- The Clinical Impact and Cost Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in Finland
- (2016) Lisa Nagy et al. PHARMACOECONOMICS
- Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model
- (2016) Christiaan Dolk et al. PHARMACOECONOMICS
- Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination?
- (2016) Saverio Caini et al. PLoS One
- Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States
- (2016) Pieter T. de Boer et al. VALUE IN HEALTH
- Estimates of the Public Health Impact of a Pediatric Vaccination Program Using an Intranasal Tetravalent Live-Attenuated Influenza Vaccine in Belgium
- (2016) Laetitia Gerlier et al. PEDIATRIC DRUGS
- Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe
- (2016) Mathieu Uhart et al. Human Vaccines & Immunotherapeutics
- Cost–effectiveness analysis of quadrivalent influenza vaccine in Spain
- (2016) Amos García et al. Human Vaccines & Immunotherapeutics
- Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach
- (2016) Anita J. Brogan et al. Human Vaccines & Immunotherapeutics
- Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model
- (2016) Ming-Chin Yang et al. Human Vaccines & Immunotherapeutics
- A comprehensive review of the epidemiology and disease burden of Influenza B in 9 European countries
- (2016) Monica Tafalla et al. Human Vaccines & Immunotherapeutics
- Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion Proteins
- (2016) Lynda Tussey et al. Open Forum Infectious Diseases
- Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom
- (2015) Edward W. Thommes et al. BMC INFECTIOUS DISEASES
- Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United Kingdom
- (2015) Douglas M. Fleming et al. BMC INFECTIOUS DISEASES
- Influenza-attributable burden in United Kingdom primary care
- (2015) D. M. FLEMING et al. EPIDEMIOLOGY AND INFECTION
- Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results
- (2015) Richard Pebody et al. Eurosurveillance
- Evidence update: GlaxoSmithKline’s inactivated quadrivalent influenza vaccines
- (2015) Rafik Bekkat-Berkani et al. Expert Review of Vaccines
- Fluarix quadrivalent vaccine for influenza
- (2015) Hans de Graaf et al. Expert Review of Vaccines
- Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study
- (2015) Saverio Caini et al. Influenza and Other Respiratory Viruses
- Retrospective public health impact of a quadrivalent influenza vaccine in the United States
- (2015) Pascal Crépey et al. Influenza and Other Respiratory Viruses
- Comparative Burden of Influenza A/H1N1, A/H3N2 and B Infections in Children Treated as Outpatients
- (2015) Heli Silvennoinen et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Safety and immunogenicity of a quadrivalent intradermal influenza vaccine in adults
- (2015) Geoffrey J. Gorse et al. VACCINE
- Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors
- (2015) Ayman Chit et al. VACCINE
- Influenza: Can we cope better with the unpredictable?
- (2015) Gaël Dos Santos et al. Human Vaccines & Immunotherapeutics
- Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong – A decision analysis
- (2015) Joyce H S You et al. Human Vaccines & Immunotherapeutics
- Cost-effectiveness analysis of quadrivalent influenza vaccination in at-risk adults and the elderly: an updated analysis in the UK
- (2015) G. Meier et al. JOURNAL OF MEDICAL ECONOMICS
- Incidence of medically attended influenza during pandemic and post-pandemic seasons through the Influenza Incidence Surveillance Project, 2009–13
- (2015) Ashley Fowlkes et al. Lancet Respiratory Medicine
- An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model
- (2015) Ayman Chit et al. PLoS One
- Clinical Characteristics Are Similar across Type A and B Influenza Virus Infections
- (2015) Anne Mosnier et al. PLoS One
- Striking Similarities in the Presentation and Duration of Illness of Influenza A and B in the Community: A Study Based on Sentinel Surveillance Networks in France and Turkey, 2010-2012
- (2015) Jean Marie Cohen et al. PLoS One
- Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
- (2014) Joyce HS You et al. BMC INFECTIOUS DISEASES
- 4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany
- (2014) Martin Eichner et al. BMC INFECTIOUS DISEASES
- Impact of Influenza B Lineage-Level Mismatch Between Trivalent Seasonal Influenza Vaccines and Circulating Viruses, 1999–2012
- (2014) Terho Heikkinen et al. CLINICAL INFECTIOUS DISEASES
- Burden of influenza B virus infections in Scotland in 2012/13 and epidemiological investigations between 2000 and 2012
- (2014) H Harvala et al. Eurosurveillance
- Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status
- (2014) Gonçalo Matias et al. Influenza and Other Respiratory Viruses
- Influenza A/Subtype and B/Lineage Effectiveness Estimates for the 2011–2012 Trivalent Vaccine: Cross-Season and Cross-Lineage Protection With Unchanged Vaccine
- (2014) Danuta M. Skowronski et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
- (2014) Carlos A. DiazGranados et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of an Inactivated Quadrivalent Influenza Vaccine in Children 6 Months through 8 Years of Age
- (2014) David P. Greenberg et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: A phase III, randomized trial
- (2014) Juan Carlos Tinoco et al. VACCINE
- Cost Effectiveness of Quadrivalent Influenza Vaccine Over Trivalent Vaccine in France
- (2014) G. Duru et al. VALUE IN HEALTH
- Quadrivalent Influenza Vaccine in Hong Kong- a Cost-Effectiveness Analysis
- (2014) J. You et al. VALUE IN HEALTH
- Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination
- (2014) Emma Quinn et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States
- (2014) Karen M Clements et al. Human Vaccines & Immunotherapeutics
- The Burden of Influenza B: A Structured Literature Review
- (2013) W. Paul Glezen et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years
- (2013) Dorothee Kieninger et al. BMC INFECTIOUS DISEASES
- Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis
- (2013) Andrea C Tricco et al. BMC Medicine
- Inactivated Quadrivalent Split-Virus Seasonal Influenza Vaccine (Fluarix® Quadrivalent): A Review of Its Use in the Prevention of Disease Caused by Influenza A and B
- (2013) Kate McKeage DRUGS
- The evolving history of influenza viruses and influenza vaccines
- (2013) Claude Hannoun Expert Review of Vaccines
- Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children
- (2013) Joanne M. Langley et al. JOURNAL OF INFECTIOUS DISEASES
- A Randomized Trial of Candidate Inactivated Quadrivalent Influenza Vaccine versus Trivalent Influenza Vaccines in Children Aged 3–17 Years
- (2013) Joseph B. Domachowske et al. JOURNAL OF INFECTIOUS DISEASES
- Hospital-based influenza surveillance in Korea: Hospital-based influenza morbidity and mortality study group
- (2013) Joon Young Song et al. JOURNAL OF MEDICAL VIROLOGY
- Differing Epidemiological Dynamics of Influenza B Virus Lineages in Guangzhou, Southern China, 2009-2010
- (2013) Y. Tan et al. JOURNAL OF VIROLOGY
- Vaccine for Prevention of Mild and Moderate-to-Severe Influenza in Children
- (2013) Varsha K. Jain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Influenza-Associated Pediatric Deaths in the United States, 2004-2012
- (2013) K. K. Wong et al. PEDIATRICS
- Surveillance and Vaccine Effectiveness of an Influenza Epidemic Predominated by Vaccine-Mismatched Influenza B/Yamagata-Lineage Viruses in Taiwan, 2011−12 Season
- (2013) Yi-Chun Lo et al. PLoS One
- A Comparison of the Clinical and Epidemiological Characteristics of Adult Patients with Laboratory-Confirmed Influenza A or B during the 2011–2012 Influenza Season in Korea: A Multi-Center Study
- (2013) Seong-Heon Wie et al. PLoS One
- Influenza B Lineage Circulation and Hospitalization Rates in a Subtropical City, Hong Kong, 2000–2010
- (2012) Paul K. S. Chan et al. CLINICAL INFECTIOUS DISEASES
- Quadrivalent Ann Arbor strain live-attenuated influenza vaccine
- (2012) Seth L Toback et al. Expert Review of Vaccines
- Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow-fill-seal device in adults: a randomized, active-controlled study*
- (2012) Eric A. Sheldon et al. Influenza and Other Respiratory Viruses
- Excess Mortality Associated With Influenza A and B Virus in Hong Kong, 1998–2009
- (2012) Peng Wu et al. JOURNAL OF INFECTIOUS DISEASES
- Myocardial Injury and Bacterial Pneumonia Contribute to the Pathogenesis of Fatal Influenza B Virus Infection
- (2012) Christopher D. Paddock et al. JOURNAL OF INFECTIOUS DISEASES
- Immunogenicity and Safety of a Quadrivalent Live Attenuated Influenza Vaccine in Children
- (2012) Stan L. Block et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Nationwide Surveillance of Influenza during the Pandemic (2009–10) and Post-Pandemic (2010–11) Periods in Taiwan
- (2012) Jen-Hsiang Chuang et al. PLoS One
- Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine
- (2012) Carrie Reed et al. VACCINE
- Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults
- (2012) David P. Greenberg et al. VACCINE
- Correlates of vaccine protection from influenza and its complications
- (2012) Jonathan A. McCullers et al. Human Vaccines & Immunotherapeutics
- The rationale for quadrivalent influenza vaccines
- (2012) Christopher S. Ambrose et al. Human Vaccines & Immunotherapeutics
- Clinical and socioeconomic impact of different types and subtypes of seasonal influenza viruses in children during influenza seasons 2007/2008 and 2008/2009
- (2011) Susanna Esposito et al. BMC INFECTIOUS DISEASES
- Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four seasons: 2004-2005 through 2007-2008
- (2011) Stephanie A. Irving et al. Influenza and Other Respiratory Viruses
- A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults
- (2011) Stan L. Block et al. VACCINE
- Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project
- (2010) W. John Paget et al. EUROPEAN JOURNAL OF PEDIATRICS
- The need for quadrivalent vaccine against seasonal influenza
- (2010) Robert B. Belshe VACCINE
- Efficacy of Inactivated Split‐Virus Influenza Vaccine against Culture‐Confirmed Influenza in Healthy Adults: A Prospective, Randomized, Placebo‐Controlled Trial
- (2009) Jiri Beran et al. JOURNAL OF INFECTIOUS DISEASES
- Clinical and genetic characterization of severe influenza B-associated diseases during an outbreak in Taiwan
- (2008) Wen-Chen Li et al. JOURNAL OF CLINICAL VIROLOGY
- Component‐Specific Effectiveness of Trivalent Influenza Vaccine as Monitored through a Sentinel Surveillance Network in Canada, 2006–2007
- (2008) Danuta M. Skowronski et al. JOURNAL OF INFECTIOUS DISEASES
- The Evolutionary Dynamics of Human Influenza B Virus
- (2008) Rubing Chen et al. JOURNAL OF MOLECULAR EVOLUTION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation